drugset / Trial / NCT05372809
Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of SkinTE for treatment of Wagner grade 2 diabetic foot ulcers.
Timeline
- Start
- 2022-04-28
- Primary completion
- 2024-02-21
- Completion
- 2024-02-21
Outcome
Outcome not reported
Stopped (Enrollment): “Study terminated due to slow enrollment and change in strategy.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SkinTE | Cell therapy | — | — |
Indications
No indication recorded.